Literature DB >> 28135253

Alternative pathway for the development of Vα14+ NKT cells directly from CD4-CD8- thymocytes that bypasses the CD4+CD8+ stage.

Nyambayar Dashtsoodol1,2, Tomokuni Shigeura1, Minako Aihara1, Ritsuko Ozawa1, Satoshi Kojo1, Michishige Harada1, Takaho A Endo3, Takashi Watanabe3, Osamu Ohara3, Masaru Taniguchi1.   

Abstract

Although invariant Vα14+ natural killer T cells (NKT cells) are thought to be generated from CD4+CD8+ double-positive (DP) thymocytes, the developmental origin of CD4-CD8- double-negative (DN) NKT cells still remains unresolved. Here we provide definitive genetic evidence obtained, through studies of mice with DP-stage-specific ablation of expression of the gene encoding the recombinase component RAG-2 (Rag2) and by a fate-mapping approach, that supports the proposal of the existence of an alternative developmental pathway through which a fraction of DN NKT cells with strong T-helper-type-1 (TH1)-biased and cytotoxic characteristics develop from late DN-stage thymocytes, bypassing the DP stage. These findings provide new insight into understanding of the development of NKT cells and propose a role for timing of expression of the invariant T cell antigen receptor in determining the functional properties of NKT cells.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28135253     DOI: 10.1038/ni.3668

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  43 in total

1.  Requirement for RORgamma in thymocyte survival and lymphoid organ development.

Authors:  Z Sun; D Unutmaz; Y R Zou; M J Sunshine; A Pierani; S Brenner-Morton; R E Mebius; D R Littman
Journal:  Science       Date:  2000-06-30       Impact factor: 47.728

2.  NKT cells derive from double-positive thymocytes that are positively selected by CD1d.

Authors:  L Gapin; J L Matsuda; C D Surh; M Kronenberg
Journal:  Nat Immunol       Date:  2001-10       Impact factor: 25.606

Review 3.  Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs.

Authors:  Jason G Cyster
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

4.  Genetic evidence supporting selection of the Valpha14i NKT cell lineage from double-positive thymocyte precursors.

Authors:  Takeshi Egawa; Gerard Eberl; Ichiro Taniuchi; Kamel Benlagha; Frederic Geissmann; Lothar Hennighausen; Albert Bendelac; Dan R Littman
Journal:  Immunity       Date:  2005-06       Impact factor: 31.745

5.  Recognition of bacterial glycosphingolipids by natural killer T cells.

Authors:  Yuki Kinjo; Douglass Wu; Gisen Kim; Guo-Wen Xing; Michael A Poles; David D Ho; Moriya Tsuji; Kazuyoshi Kawahara; Chi-Huey Wong; Mitchell Kronenberg
Journal:  Nature       Date:  2005-03-24       Impact factor: 49.962

6.  Methods for detection, isolation and culture of mouse and human invariant NKT cells.

Authors:  Hiroshi Watarai; Ryusuke Nakagawa; Miyuki Omori-Miyake; Nyambayar Dashtsoodol; Masaru Taniguchi
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

7.  The timing of TCR alpha expression critically influences T cell development and selection.

Authors:  Troy A Baldwin; Michelle M Sandau; Stephen C Jameson; Kristin A Hogquist
Journal:  J Exp Med       Date:  2005-07-04       Impact factor: 14.307

8.  The E delta enhancer controls the generation of CD4- CD8- alphabetaTCR-expressing T cells that can give rise to different lineages of alphabeta T cells.

Authors:  Iannis Aifantis; Craig H Bassing; Annette I Garbe; Katie Sawai; Frederick W Alt; Harald von Boehmer
Journal:  J Exp Med       Date:  2006-06-05       Impact factor: 14.307

9.  Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining.

Authors:  Jenny E Gumperz; Sachiko Miyake; Takashi Yamamura; Michael B Brenner
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

10.  An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells.

Authors:  P Dellabona; E Padovan; G Casorati; M Brockhaus; A Lanzavecchia
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more
  26 in total

Review 1.  The ins and outs of type I iNKT cell development.

Authors:  Susannah C Shissler; Tonya J Webb
Journal:  Mol Immunol       Date:  2018-11-28       Impact factor: 4.407

Review 2.  Invariant NKT Cells and Control of the Thymus Medulla.

Authors:  Andrea J White; Beth Lucas; William E Jenkinson; Graham Anderson
Journal:  J Immunol       Date:  2018-05-15       Impact factor: 5.422

Review 3.  NKT cells in liver diseases.

Authors:  Shasha Zhu; Huimin Zhang; Li Bai
Journal:  Front Med       Date:  2018-04-06       Impact factor: 4.592

Review 4.  Liver metastases.

Authors:  Diamantis I Tsilimigras; Pnina Brodt; Pierre-Alain Clavien; Ruth J Muschel; Michael I D'Angelica; Itaru Endo; Rowan W Parks; Majella Doyle; Eduardo de Santibañes; Timothy M Pawlik
Journal:  Nat Rev Dis Primers       Date:  2021-04-15       Impact factor: 52.329

Review 5.  Thymic development of unconventional T cells: how NKT cells, MAIT cells and γδ T cells emerge.

Authors:  Daniel G Pellicci; Hui-Fern Koay; Stuart P Berzins
Journal:  Nat Rev Immunol       Date:  2020-06-24       Impact factor: 53.106

6.  Methylation of H3K27 and H3K4 in key gene promoter regions of thymus in RA mice is involved in the abnormal development and differentiation of iNKT cells.

Authors:  Ming Meng; Huifang Liu; Shengde Chen; Huijuan Zhao; Xiang Gao; Jingnan Zhang; Dongzhi Chen
Journal:  Immunogenetics       Date:  2019-07-11       Impact factor: 2.846

Review 7.  γδTCR-independent origin of neonatal γδ T cells prewired for IL-17 production.

Authors:  Nicholas A Spidale; Michela Frascoli; Joonsoo Kang
Journal:  Curr Opin Immunol       Date:  2019-05-23       Impact factor: 7.486

8.  PDCD5 regulates iNKT cell terminal maturation and iNKT1 fate decision.

Authors:  Ke Wang; Xinwei Zhang; Yifan Wang; Gaowen Jin; Mingyang Li; Shusong Zhang; Jie Hao; Rong Jin; Xiaojun Huang; Hounan Wu; Jun Zhang; Yingyu Chen; Qing Ge
Journal:  Cell Mol Immunol       Date:  2018-06-19       Impact factor: 11.530

9.  Anti-tumor effects of an ID antagonist with no observed acquired resistance.

Authors:  Paulina M Wojnarowicz; Marta Garcia Escolano; Yun-Han Huang; Bina Desai; Yvette Chin; Riddhi Shah; Sijia Xu; Saurabh Yadav; Sergey Yaklichkin; Ouathek Ouerfelli; Rajesh Kumar Soni; John Philip; David C Montrose; John H Healey; Vinagolu K Rajasekhar; William A Garland; Jeremy Ratiu; Yuan Zhuang; Larry Norton; Neal Rosen; Ronald C Hendrickson; Xi Kathy Zhou; Antonio Iavarone; Joan Massague; Andrew J Dannenberg; Anna Lasorella; Robert Benezra
Journal:  NPJ Breast Cancer       Date:  2021-05-24

Review 10.  Natural Killer T Cells: An Ecological Evolutionary Developmental Biology Perspective.

Authors:  Amrendra Kumar; Naveenchandra Suryadevara; Timothy M Hill; Jelena S Bezbradica; Luc Van Kaer; Sebastian Joyce
Journal:  Front Immunol       Date:  2017-12-22       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.